Issue 8, 2017

Mimics of pramanicin derived from pyroglutamic acid and their antibacterial activity

Abstract

Mono and dihydroxypyrrolidinones are readily available by direct oxygenation of a pyroglutamate-derived bicyclic lactam with high diastereoselectivity, and these may be manipulated further in protected or unprotected form by Grignard addition to a pendant Weinreb amide to give acylhydroxypyrrolidinones, which are analogues of the natural product, pramanicin. Preliminary bioassay against S. aureus and E. coli indicated that some compounds exhibit selective Gram-negative antibacterial activity, and may offer promise for the development of novel systems suitable for antibacterial drug development.

Graphical abstract: Mimics of pramanicin derived from pyroglutamic acid and their antibacterial activity

Supplementary files

Article information

Article type
Paper
Submitted
30 Dec 2016
Accepted
30 Jan 2017
First published
31 Jan 2017

Org. Biomol. Chem., 2017,15, 1889-1912

Mimics of pramanicin derived from pyroglutamic acid and their antibacterial activity

S. W. B. Tan, C. L. L. Chai and M. G. Moloney, Org. Biomol. Chem., 2017, 15, 1889 DOI: 10.1039/C6OB02828D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements